JIUYUAN GENE (02566) spent about HKD 5.7284 million to repurchase 538,400 shares on February 3rd.
GenScript Biotech Corporation (02566) announced that on February 3, 2026, it repurchased approximately 538,400 shares at a cost of approximately HK$5.7284 million.
JIUYUAN GENE (02566) announced that on February 3, 2026, it spent approximately HK$5.7284 million to repurchase 538,400 shares.
Related Articles

NATURAL BEAUTY(00157) announces a profit of approximately HK$8-10 million for the year, turning losses into profits compared to the previous year.

Pfizer Inc. (PFE.US) reported better-than-expected Q4 earnings, but investors are more concerned about whether the weight loss drug can support further growth.

GRACEWINE (08146) appoints Liu Yunqiang, Xiong Xia, and Zhao Mingjun as executive directors.
NATURAL BEAUTY(00157) announces a profit of approximately HK$8-10 million for the year, turning losses into profits compared to the previous year.

Pfizer Inc. (PFE.US) reported better-than-expected Q4 earnings, but investors are more concerned about whether the weight loss drug can support further growth.

GRACEWINE (08146) appoints Liu Yunqiang, Xiong Xia, and Zhao Mingjun as executive directors.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


